Home/Filings/4/0000950170-24-087383
4//SEC Filing

Wyatt Christopher F. 4

Accession 0000950170-24-087383

CIK 0000860730other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 5:25 PM ET

Size

21.9 KB

Accession

0000950170-24-087383

Insider Transaction Report

Form 4
Period: 2024-07-25
Wyatt Christopher F.
SVP & Controller
Transactions
  • Tax Payment

    Common Stock

    2024-07-25$352.79/sh5,278$1,862,02644,449 total
  • Exercise/Conversion

    Stock Appreciation Right

    2024-07-259,3000 total
    Exercise: $101.16Exp: 2028-01-31Common Stock (9,300 underlying)
  • Sale

    Common Stock

    2024-07-29$360.20/sh4,000$1,440,78240,449 total
  • Exercise/Conversion

    Common Stock

    2024-07-25$101.16/sh+9,300$940,78849,727 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.05 to $360.205, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001673365

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 5:25 PM ET
Size
21.9 KB